Metraipolis › archive › dc_2f906056ff42
Real-World Clinical Outcomes of Azacitidine Versus Best Supportive Care in Higher-Risk Myelodysplastic Neoplasms: A Single-Center Cohort Study — Europe PMC PMID:42201004
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42201004
- DOI
- 10.3390/medsci14020212
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T06:55:28.275Z
- SHA-256 of the archived text
6cad9deb49a9916c7647361725a308ef35f6027ea32f11a7ed3647535b309fac- Stable URL of this page
https://metraipolis.com/documento/dc_2f906056ff42
How to cite
Real-World Clinical Outcomes of Azacitidine Versus Best Supportive Care in Higher-Risk Myelodysplastic Neoplasms: A Single-Center Cohort Study — Europe PMC PMID:42201004 — Europe PMC (en), https://europepmc.org/article/MED/42201004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f906056ff42 (Metraipolis archive dc_2f906056ff42, sha256 6cad9deb49a9916c7647361725a308ef35f6027ea32f11a7ed3647535b309fac)
BibTeX
@misc{dc2f906056ff42,
title = {Real-World Clinical Outcomes of Azacitidine Versus Best Supportive Care in Higher-Risk Myelodysplastic Neoplasms: A Single-Center Cohort Study — Europe PMC PMID:42201004},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42201004},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f906056ff42; sha256 6cad9deb49a9916c7647361725a308ef35f6027ea32f11a7ed3647535b309fac},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201004. Agents can read the archived copy with the MCP tool read_document.